UCLA David Geffen School of Medicine
Division of General Internal Medicine and Health Services Research
Dr. Tseng received his Ph.D in Biostatistics from UCLA in 2004. His research interest includes design of clinical trials, survival analysis, multiple comparisons problem, and statistical genetics. He has extensive collaborative experience in cardiology, infectious disease, pulmonary, nephrology, cancer, and health services studies.
Heath SC, Snow GL, Thompson EA, Tseng CH, and Wijsman EM. MCMC segregation and linkage analysis. Genet Epidemiol. 1997;14(6):1011-6.
Thall P, Lee JJ and Tseng CH. Accrual Strategies for Phase I Trials With Delayed Patient Outcome. Stat Med. 1999 May 30;18(10):1155-69.
Lee JJ and Tseng CH. Uniform power method for sample size calculation in historical control studies with binary response. Control Clin Trials. 2001 Aug;22(4):390-400.
Shao YZ, Tseng CH. Sample size calculation with dependence adjustment for FDR-control in microarray studies. Stat Med. 2007 Oct 15;26(23):4219-37.
Ge YC, Sealfon S, Tseng CH, and Speed T. A Holm-type procedure controlling the false discovery rate. Statistics and Probability Letters. 2007 Dec;77:1756-1762.
Li G, Tseng CH. Nonparametric estimation of a survival function with two-stage design studies. Scand Stat Theory Appl. 2008 Jun 1;35(2):228-247.
Tseng CH, Liu M. Joint modeling of survival data and longitudinal measurements under nested case-control sampling. Statistics in Biopharmaceutical Research. 2009 Nov;1(4):415-423.
Liu M, Lu W, Tseng CH. Cox Regression in Nested Case-controls Studies with Auxiliary Covariates. Biometrics. 2010 Jun;66(2):374-81.
Tseng CH, Shao Y. Sample size calculation for pharmacogenomics study. Statistics in Biopharmaceutical Research. 2010 Aug;2(3):319-328.
Tseng CH, Wong WK. Analysis of a Composite Endpoint with Longitudinal and Time-to-Event Data. Stat Med. 2011 Apr 30;30(9):1018-27.